ChromaDex Corporation

NasdaqCM:CDXC Stock Report

Market Cap: US$420.3m

ChromaDex Future Growth

Future criteria checks 4/6

ChromaDex is forecast to grow earnings and revenue by 81.8% and 18.1% per annum respectively while EPS is expected to grow by 82.7% per annum.

Key information

81.8%

Earnings growth rate

82.7%

EPS growth rate

Life Sciences earnings growth17.8%
Revenue growth rate18.1%
Future return on equityn/a
Analyst coverage

Low

Last updated06 Dec 2024

Recent future growth updates

Recent updates

ChromaDex's (NASDAQ:CDXC) Solid Earnings Are Supported By Other Strong Factors

Nov 07
ChromaDex's (NASDAQ:CDXC) Solid Earnings Are Supported By Other Strong Factors

Revenues Tell The Story For ChromaDex Corporation (NASDAQ:CDXC) As Its Stock Soars 70%

Nov 05
Revenues Tell The Story For ChromaDex Corporation (NASDAQ:CDXC) As Its Stock Soars 70%

ChromaDex Corporation (NASDAQ:CDXC) Stock Rockets 25% But Many Are Still Ignoring The Company

Jul 25
ChromaDex Corporation (NASDAQ:CDXC) Stock Rockets 25% But Many Are Still Ignoring The Company

Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable

Jun 15
Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable

Positive Sentiment Still Eludes ChromaDex Corporation (NASDAQ:CDXC) Following 26% Share Price Slump

Jun 05
Positive Sentiment Still Eludes ChromaDex Corporation (NASDAQ:CDXC) Following 26% Share Price Slump

Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?

Apr 05
Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?

Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet

Feb 28
Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet

ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price

Jan 29
ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price

Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

Jun 08
Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely

Mar 31
We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely

ChromaDex inks new commercial supply agreement for its Niagen ingredient with Nestlé

Oct 11

ChromaDex forms JV in Asia for Tru Niagen; plans to raise $3.1M via stock sale

Oct 03

ChromaDex in pact to introduce anti-aging compound in Brazil

Sep 01

Ayana Bio appoints Frank Jaksch as CEO

Aug 24

ChromaDex wins patent challenge as US regulator rejects Thorne Research's demand to invalidate patent

Aug 15

Earnings and Revenue Growth Forecasts

NasdaqCM:CDXC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261361315152
12/31/20251181011114
12/31/2024973465
9/30/202492144N/A
6/30/202486-111N/A
3/31/202483-455N/A
12/31/202384-577N/A
9/30/202383-666N/A
6/30/202381-622N/A
3/31/202377-11-6-5N/A
12/31/202272-17-15-15N/A
9/30/202269-20-20-20N/A
6/30/202269-28-22-22N/A
3/31/202270-27-26-26N/A
12/31/202167-27-25-24N/A
9/30/202165-28-20-19N/A
6/30/202162-23-17-17N/A
3/31/202160-21-11-11N/A
12/31/202059-20-11-11N/A
9/30/202057-23-12-11N/A
6/30/202055-26-16-15N/A
3/31/202051-30-23-23N/A
12/31/201946-32-21-20N/A
9/30/201942-32-26-25N/A
6/30/201938-33-23-22N/A
3/31/201935-33-22-20N/A
12/31/201832-33-22-21N/A
9/30/201830-34-21-20N/A
6/30/201828-29N/A-15N/A
3/31/201824-23N/A-14N/A
12/30/201721-17N/A-10N/A
9/30/201718-10N/A-6N/A
7/1/201716-8N/A-6N/A
4/1/201718-6N/A0N/A
12/31/201622-4N/A-3N/A
10/1/201622-3N/A-4N/A
7/2/201624-2N/A-5N/A
4/2/201624-1N/A-4N/A
1/2/201618-3N/A-2N/A
10/3/201522-3N/A-2N/A
7/4/201520-3N/A-1N/A
4/4/201518-5N/A-2N/A
1/3/201515-5N/A-3N/A
9/27/201413-5N/A-4N/A
6/28/201412-5N/A-4N/A
3/29/201411-5N/A-5N/A
12/28/201310-4N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CDXC's forecast earnings growth (81.8% per year) is above the savings rate (2.6%).

Earnings vs Market: CDXC's earnings (81.8% per year) are forecast to grow faster than the US market (15.2% per year).

High Growth Earnings: CDXC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CDXC's revenue (18.1% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: CDXC's revenue (18.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CDXC's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ChromaDex Corporation is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
Jeffrey Van SinderenB. Riley Securities, Inc.
Robert WassermanDawson James Securities